Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Every 3 Week Versus Weekly Cisplatin Concurrent With Radiation in SCCHN
NCT02994069Phase 2Active, not recruiting
- Start
- Apr 2017
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in squamous cell carcinoma of the head and neck (HNSCC). Started Apr 2017; status: active, not recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02994069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994069.